Diabetes and Liver Disease: The Hidden Link You Cannot Ignore
For many people living with Type 2 diabetes, routine check-ups focus on blood sugar levels, medication, and heart health. But doctors are increasingly warning that the liver—a key metabolic organ—deserves equal attention. A growing body of evidence shows that diabetes and liver disease are closely connected, and ignoring this link can lead to serious complications.
Dr. Ramesh (name changed), a 58-year-old patient with a decade-long history of Type 2 diabetes, recently visited his doctor for a routine review. Instead of discussing only his HbA1c levels, the doctor recommended a liver function test and asked about hepatitis B vaccination. The patient was baffled. “I have diabetes. Why are we talking about my liver?” he asked. His doctor explained that he had silently developed fatty liver disease—a common but often overlooked complication of diabetes.
Medical experts say this scenario is all too common. People with Type 2 diabetes have a significantly higher risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease. In this condition, insulin resistance causes fat to accumulate in the liver. Over time, this can lead to inflammation, scarring (cirrhosis), and even liver cancer. Yet, because early stages are symptom-free, many patients are unaware of the damage.
The connection extends to viral hepatitis as well. People with diabetes are at an increased risk of hepatitis B, particularly in settings where infection control during medical procedures or glucose monitoring is lax. Hepatitis C, on the other hand, can worsen insulin resistance and increase the likelihood of developing Type 2 diabetes. The relationship is bidirectional: each condition influences the other.
Once liver damage occurs, managing diabetes becomes more difficult. A damaged liver cannot regulate blood sugar effectively, leading to unpredictable glucose fluctuations. Additionally, many diabetes medications are processed by the liver, requiring dose adjustments in patients with advanced liver disease.
Despite these risks, liver health is often neglected in routine diabetes care. Doctors recommend regular screening through liver function tests and ultrasound examinations, especially for patients with additional risk factors such as a history of blood transfusions, unsafe injections, or a family history of hepatitis.
“Rather than waiting for symptoms—which often appear only after significant damage—proactive screening is the best way to catch liver problems early, when they are most treatable,” says a senior hepatologist.
For the millions of Indians living with diabetes, this message is critical. With the country seeing a rising burden of both diabetes and liver disease, integrated care that addresses both conditions could prevent thousands of cases of cirrhosis and liver cancer.
